Thanks skorpian great input.
In respect of another previous question here regarding OSL being either a single product company or does it have other products on the go, which I would doubt at this stage of the Company's life, I am under the impression their technology might be described as 'platform technology' which in effect must mean their process could be applied to other cancer types. Can you advise if this is correct please?
thanks
redgum
Cash Flow Report, page-4
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.79M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.8¢ | $15.59K | 1.950M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 69 | 33714048 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 53583 | 3 |
View Market Depth
| Last trade - 12.18pm 13/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |